Data & Analytics

Aptus Health is leveraging artificial intelligence to provide its clients with a deeper understanding of how HCPs consume data to better equip them to reach, engage with and influence this critical cohort.

Developments in data-collection and artificial-intelligence tools will impact how pharma marketers promote products said experts—including Tom Wassel, Director of Analytics at Aptus Health—at the ePharma Impact conference in New York on Wednesday.

To help our client re-educate physicians on a new indication for a therapy, we developed a data-driven digital campaign driven by our proprietary Aptus Propensity Index™ that funnels individual HCPs into different engagement journeys based on historical and predictive behaviors. 

To capitalize on its brands’ favorable formulary positioning, we helped our client develop a Market Access Pull-Through Program (MAPP) powered by Aptus Health’s Tomorrow Networks division.

We’re honored to have been named a finalist in the 2018 MM&M Awards in the “Best use of Data/Analytics” category for our entry, “Boehringer Ingelheim and Aptus Health for Spiriva Respimat: Synchronized HCP and Consumer Campaign at the Point of Care and Beyond.” 

Our own David Laros, VP of analytics and commercial effectiveness, is quoted alongside other industry experts in this recent article that appears in PharmaVOICE magazine, underscoring  the power of predictive data and the value of analyzing disparate data sets across multiple healthcare…

Our VP of analytics and commercial effectiveness sits down for a brief interview with an editor from MM&M magazine to discuss how pharma can use data insights to foster engagement with HCPs.

It's not exactly chemistry, but there is a science to our approach to data and analytics, which is rigorously designed to build and sustain the trust our clients put in us.  From target selection to final measurement reports, we take a completely verifiable approach to communicating the…